Compare · head to head
Eisai vs Jeil Pharmaceutical
Dead heat overall: both rank 70 on the 360° View.
Eisai leads on Value (81 vs 54) and Sentiment (52 vs 46). Jeil Pharmaceutical leads on Quality (55 vs 39) and Growth (60 vs 39). The two are close on Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Japan | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Large | Small |
| ISIN | JP3160400002 | KR7271980005 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 70 | 70 |
| Value | 81 | 54 |
| Quality | 39 | 55 |
| Growth | 39 | 60 |
| Safety | 60 | 56 |
| Sentiment | 52 | 46 |
| Quality details | ||
| Profitability | 30 | 81 |
| Cash Truth | 48 | 29 |
Eisai vs Towa PharmaceuticalEisai vs JW PharmaceuticalEisai vs Jeil PharmaEisai vs Lotus PharmaceuticalAdd a third stock →
Full analyses: Eisai · Jeil Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100